Shanghai Rendu Biotechnology Co., Ltd.SSE: 688193

(688193)"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Report for Q3 2026

Oct 30, 2026 · Issued by Shanghai Rendu Biotechnology Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688193 · Oct 30, 2026

On 6ix: 6ix.com/news/688193shanghai-rendu-biotechnology-co-ltdreport-for-q3-2026

Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment

6ix is reading this filing.

View original source (Shanghai Stock Exchange)Shanghai Rendu Biotechnology Co., Ltd. on 6ix

Earlier from Shanghai Rendu Biotechnology

(688193)"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement on Completion of Registration Change of the Legal Representative and Issuance of a New Business LicenseOct 23
(688193)"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement on Election of Employee Representative Director for the 3rd Board of DirectorsSep 29
(688193)"SHANGHAI RENDU BIOTECHNOLOGY CO., LTD."Announcement on Completion of Election of New Board of Directors, Appointment of Senior Executives and Securities Affairs Representative, Designation of the Chairman to Act as the Board Secretary, and Designation of a Person to Act as the Chief Financial OfficerSep 29
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Sep 29
Announcement on Election of New Board of DirectorsSep 12

All Shanghai Rendu Biotechnology news releases

Follow Shanghai Rendu Biotechnology into a list and get an email when it puts out news.

Follow Shanghai Rendu Biotechnology